Tuesday, 15 October 2019

Generics News

  • CHMP backs Sanofi's Dupixen in asthma

    Generics |  News | 0 Comment | 08 Mar, 2019

    Regeneron Pharmaceuticals and Sanofi recently announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive...Read more

  • Lupin receives FDA approval for generic version Vidaza

    Generics |  News | 0 Comment | 01 Mar, 2019

    Pharma major Lupin announced that it has received approval for its Azacitidine for Injection, 100 mg Single-Dose Vial from the United States Food and Drug Administration (FDA) to market a g...Read more

  • Novartis receives FDA approval for Egaten

    Generics |  News | 0 Comment | 20 Feb, 2019

    Novartis has announced that the US Food and Drug Administration (FDA) approval of Egaten (triclabendazole) for the treatment of fascioliasis in patients six years of age and older. This mak...Read more

  • Lupin launches Tadalafil Tablets

    Generics |  News | 0 Comment | 13 Feb, 2019

    Pharma major Lupin announced the launch of Tadalafil Tablets USP 20mg, having received an approval from the United States Food and Drug Administration (FDA) earlier. Lupin’s Tadalafi...Read more

  • Lupin receives FDA approval for Fluoxetine Tablets

    Generics |  News | 0 Comment | 13 Feb, 2019

    Pharma major Lupin announced that it has received approval for its Fluoxetine Tablets USP, 60mg, from the United States Food and Drug Administration (FDA) to market a generic version of Alv...Read more

  • Lupin announces launch of NaMuscla

    Generics |  News | 0 Comment | 04 Feb, 2019

    India based pharma company Lupin has announced the launch of NaMuscla® (mexiletine) in Germany and the United Kingdom (UK). NaMuscla® is approved across the European Union (EU) for ...Read more

  • Mylan's generic version of ADVAIR DISKUS for asthma, COPD patients gets FDA approval

    Generics |  News | 0 Comment | 01 Feb, 2019

    Mylan has announced the U.S. Food and Drug Administration approval of Wixela Inhub (fluticasone propionate and salmeterol inhalation powder, USP), the first generic of ADVAIR DISKUS. Wixel...Read more

  • Cipla receives approval for Pfizer’s Depo-Provera

    Generics |  News | 0 Comment | 28 Jan, 2019

    Global pharma company, Cipla has announced that it has received final approval for its Abbreviated New Drug Application (ANDA) for Medroxyprogesterone Injectable, 150mg/mL from the United S...Read more

  • Glenmark receives tentative ANDA approval for Topiramate

    Generics |  News | 0 Comment | 24 Jan, 2019

    Glenmark Pharmaceuticals Inc., has been granted tentative approval by the United States Food & Drug Administration (U.S. FDA) for Topiramate Extended-Release Capsules, 25 mg, 50 mg, 100...Read more

  • Lupin receives FDA approval for Levothyroxine Sodium Tablets

    Generics |  News | 0 Comment | 22 Jan, 2019

    Indian Pharma major Lupin announced that it has received approval for its Levothyroxine Sodium Tablets USP, 25 mcg, 50 mcg, 75 mcg,  88 mcg, 100 mcg, 112 mcg, 125 mcg, 137 mcg, 150 mcg...Read more

  • J&J completes acquisition of Ci:z Holdings

    Generics |  News | 0 Comment | 18 Jan, 2019

    Johnson & Johnson has announced the completion of the acquisition of Ci:z Holdings Co., Ltd. for a total purchase price of approximately ¥230 billion. The acquisition was completed...Read more

  • Aurobindo Pharma’s subsidiary to acquire products from Spectrum Pharma

    Generics |  News | 0 Comment | 18 Jan, 2019

    Aurobindo Pharma announces the signing of a definitive agreement to acquire a portfolio of seven branded oncology injectable products from Spectrum pharmaceuticals Inc. The acquisition also...Read more

  • Lupin’s NaMuscla receives EC Approval

    Generics |  News | 0 Comment | 08 Jan, 2019

    Lupin has announced that the European Commission (EC) has approved NaMuscla® (mexiletine) for the symptomatic treatment of myotonia in adults with non-dystrophic myotonic (NDM) disorder...Read more

  • Hetero Labs limited acquires Tarbis Farma

    Generics |  News | 0 Comment | 02 Jan, 2019

    Telangana based Pharma company, Hetero has announced that its European subsidiary Amarox Limited has acquired Tarbis Farma, S.L.U., a company operating in Spain from Grupo Ferrer Internacio...Read more

  • JHL Biotech declares Phase III Study of JHL1101

    Generics |  News | 0 Comment | 28 Dec, 2018

    JHL Biotech announced today that the first patient at Beijing Cancer Hospital has been successfully randomized in the Phase III study of JHL1101 to treat diffuse large B-cell lymphoma ...Read more

  • Dr. Reddy's lab announces the launch of Sevelamer Carbonate in US

    Generics |  News | 0 Comment | 28 Dec, 2018

    Dr. Reddy’s today announced the launch of Sevelamer Carbonate for Oral Suspension, in 0.8 g and 2.4 g packets. It is a therapeutic equivalent generic version of Renvela (sevelamer ca...Read more

  • Dr. Reddy's launches Aspirin and Extended-Release Dipyridamole Capsules in USA

    Generics |  News | 0 Comment | 27 Dec, 2018

    Dr. Reddy’s has announced the launch of Aspirin and Extended-Release Dipyridamole Capsules, a therapeutic equivalent generic version of Aggrenox (aspirin and extended-release dipyrida...Read more

  • The Changing API Industry

    Generics |  Opinion | By Priyanka Bajpai | 0 Comment | 17 Dec, 2018

    Growth in healthcare adoption has benefited the API market immensely. There is greater focus on accessibility to affordable healthcare and this has led to increased surge for acce...Read more



Podcast

 

Survey Box

Is Asia-Pacific dominating the global digital transformation in healthcare market?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls